SPY308.08+2.53 0.83%
DIA257.85+2.58 1.01%
IXIC9,608.38+56.33 0.59%

HC Wainwright & Co. Reiterates Neutral on Ironwood Pharmaceuticals, Lowers Price Target to $11

HC Wainwright & Co. reiterates Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Neutral and lowers the price target from $13 to $11.

Benzinga · 05/11/2020 11:42

HC Wainwright & Co. reiterates Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Neutral and lowers the price target from $13 to $11.